Ποια είναι η τιμή για Asensus Surgical, Inc. (ASXC)

Η τιμή για Asensus Surgical, Inc. (ASXC) είναι $0.3479

Ποια είναι η κεφαλαιοποίηση αγοράς για Asensus Surgical, Inc. (ASXC)

Η κεφαλαιοποίηση αγοράς για Asensus Surgical, Inc. (ASXC) είναι $94.92M

Asensus Surgical, Inc. (ASXC) Μετοχές σε Κυκλοφορία

Asensus Surgical, Inc., a medical technology enterprise established in 2006 and headquartered in Durham, North Carolina, focuses on the research, development, and commercialization of robotic medical devices. Its core mission is to elevate minimally invasive surgical procedures throughout the United States, Europe, and Asia through innovative robotic solutions. The company's unique approach involves digitally bridging the gap between surgeons and patients, thereby introducing a new paradigm of "Performance-Guided surgery." This system aims to equip surgeons with critical clinical intelligence, ensuring consistently superior patient outcomes and setting a higher benchmark for surgical standards. Key products include the Senhance Surgical system, a multi-port robotic platform that can maneuver up to four arms to precisely control surgical instruments and a camera during laparoscopic operations. Their product line also features a range of specialized instruments, such as 3mm diameter instruments, 3mm and 5mm hooks, and articulating tools. Additionally, they offer the Senhance ultrasonic system, an advanced energy device designed for accurate, controlled tissue ligation and division. The company, initially known as TransEnterix, Inc., officially rebranded to Asensus Surgical, Inc. in February 2021.

Έτος	Κυκλοφορούντες μετοχές	Αλλαγή
2026 (TTM)	272.32M	9.06%
2023	249.69M	5.58%
2022	236.49M	4.20%
2021	226.96M	220.52%
2020	70.81M	299.22%
2019	17.74M	11.29%
2018	15.94M	-89.28%
2017	148.74M	32.59%
2016	112.19M	40.89%
2015	79.63M	35.62%
2014	58.71M	361.19%
2013	12.73M	1,080.98%
2012	1.08M	-80.75%
2011	5.60M	25.98%
2010	4.45M	23.74%
2009	3.59M	4.36%
2008	3.44M	34.86%
2007	2.55M	3,517.74%
2006	70.57K	-90.67%
2005	756.00K	53.04%
2004	494.00K	7.77%
2003	458.40K	0.00%
2002	458.40K	0.00%
2001	458.40K	0.22%
2000	457.40K	0.00%

Έτος

Κυκλοφορούντες μετοχές

Αλλαγή

2026 (TTM)

272.32M

9.06%

2023

249.69M

5.58%

2022

236.49M

4.20%

2021

226.96M

220.52%

2020

70.81M

299.22%

2019

17.74M

11.29%

2018

15.94M

-89.28%

2017

148.74M

32.59%

2016

112.19M

40.89%

2015

79.63M

35.62%

2014

58.71M

361.19%

2013

12.73M

1,080.98%

2012

1.08M

-80.75%

2011

5.60M

25.98%

2010

4.45M

23.74%

2009

3.59M

4.36%

2008

3.44M

34.86%

2007

2.55M

3,517.74%

2006

70.57K

-90.67%

2005

756.00K

53.04%

2004

494.00K

7.77%

2003

458.40K

0.00%

2002

458.40K

0.00%

2001

458.40K

0.22%

2000

457.40K

0.00%

Εταιρεία	Κυκλοφορούντες μετοχές	Διαφορά	Χώρα
Abbott Laboratories ABT.US	1.74B	540.08%	US
Stryker Corporation SYK.US	383.50M	40.83%	US
Medtronic plc MDT.US	1.28B	370.81%	IE
Boston Scientific Corporation BSX.US	1.48B	442.60%	US
Siemens Healthineers AG SHL.DE	-	-	DE

Εταιρεία

Κυκλοφορούντες μετοχές

Διαφορά

Χώρα